NIH-funded research R01 grant

Creating a kidney monitoring tool to improve treatment for high blood pressure

Official title: Building a kidney monitoring panel to guide therapy in resistant hypertension

Funded at University of Toledo Health Sci Campus · NIH-10943434 · Data updated 2026-11-12

This study is looking to create a simple urine test that helps doctors tell the difference between normal kidney changes and serious kidney problems in people who have high blood pressure that’s hard to control, so they can provide better treatment and keep your heart healthy.

More Hypertension research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Toledo Health Sci Campus
NIH-funded
Lab location1 site (Toledo, United States)
Project startJuly 1, 2024
Project endJune 30, 2028
Funding year2024
Award (this year)$651,840
NIH project number1R01HL175306-01
Project IDNIH-10943434 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include adults with resistant hypertension, particularly those with renal artery stenosis who are currently on multiple antihypertensive medications.

Less likely to help

Patients who do not have resistant hypertension or those without kidney function concerns may not benefit from this research.

What this research studies

This research aims to develop a urine-based kidney health monitoring panel that helps distinguish between benign changes in kidney function and acute kidney injury during treatment for resistant hypertension. By focusing on patients who struggle to control their blood pressure despite using multiple medications, the study seeks to improve treatment outcomes and reduce the risk of cardiovascular complications. The approach involves identifying specific biomarkers that can predict blood pressure responses and kidney health, ultimately guiding therapy decisions. Patients will be monitored closely to ensure that effective hypertension medications can be continued safely.

Why it matters

Potential benefit: If successful, this research could lead to more effective management of resistant hypertension, reducing the risk of serious cardiovascular events and improving overall kidney health.

How similar studies have gone: Other research has shown promise in using biomarker panels for kidney health monitoring, suggesting that this approach could be effective in improving hypertension treatment outcomes.

Where this research is happening

  • University of Toledo Health Sci Campus
    Toledo, United States
    Active

Researchers

  • Principal investigator: Gupta, Rajesh — University of Toledo Health Sci Campus
  • Study coordinator: Gupta, Rajesh

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.